{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Men&page=17", "query": { "condition": "Men", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 1689, "total_pages": 169, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Men&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Men&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T17:30:38.323Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02670343", "title": "Phlebotomy Study of Testosterone Undecanoate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hypogonadism" ], "interventions": [ { "name": "Oral Testosterone Undecanoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clarus Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 8, "start_date": "2016-01", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2018-03-09", "last_synced_at": "2026-10-23T17:30:38.323Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02670343" }, { "nct_id": "NCT03973840", "title": "Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypogonadism, Male" ], "interventions": [ { "name": "Testosterone Undecanoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clarus Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 13, "start_date": "2018-07-15", "completion_date": "2018-07-31", "has_results": false, "last_update_posted_date": "2019-07-09", "last_synced_at": "2026-10-23T17:30:38.323Z", "location_count": 1, "location_summary": "Northbrook, Illinois", "locations": [ { "city": "Northbrook", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03973840" }, { "nct_id": "NCT04584918", "title": "An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Aging" ], "interventions": [], "intervention_types": [], "sponsor": "Innovus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "MALE", "summary": "55 Years and older · Male only" }, "enrollment_count": 12, "start_date": "2020-10", "completion_date": "2021-01", "has_results": false, "last_update_posted_date": "2020-10-14", "last_synced_at": "2026-10-23T17:30:38.323Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04584918" }, { "nct_id": "NCT00799617", "title": "The Testosterone Trials in Older Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Andropause" ], "interventions": [ { "name": "AndroGel® (testosterone gel)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "MALE", "summary": "65 Years and older · Male only" }, "enrollment_count": 790, "start_date": "2009-11", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2019-02-21", "last_synced_at": "2026-10-23T17:30:38.323Z", "location_count": 12, "location_summary": "Birmingham, Alabama • La Jolla, California • Torrance, California + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00799617" }, { "nct_id": "NCT03037385", "title": "Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "RET-altered Non Small Cell Lung Cancer", "Medullary Thyroid Cancer", "RET-altered Papillary Thyroid Cancer", "RET-altered Colon Cancer", "RET-altered Solid Tumors", "Lung Neoplasm", "Carcinoma, Non-Small-Cell Lung", "Thyroid Diseases", "Thyroid Neoplasm", "Thyroid Cancer, Papillary", "Carcinoma, Neuroendocrine", "Respiratory Tract Neoplasms", "Thoracic Neoplasms", "Neoplasms by Site", "Neoplasms", "Lung Diseases", "Respiratory Tract Disease", "Carcinoma, Bronchogenic", "Bronchial Neoplasms", "Endocrine System Diseases", "Endocrine Gland Neoplasm", "Head and Neck Neoplasms", "Adenocarcinoma, Papillary", "Adenocarcinoma", "Carcinoma", "Neoplasms, Glandular and Epithelial", "Neoplasms by Histologic Type", "Neuroendocrine Tumors", "Neuroectodermal Tumors", "Neoplasms, Germ Cell and Embryonal", "Neoplasms, Nerve Tissue", "Colonic Neoplasms", "Colorectal Neoplasms", "Intestinal Neoplasms", "Gastrointestinal Neoplasms", "Digestive System Neoplasm", "Digestive System Disease", "Gastrointestinal Disease", "Colonic Diseases", "Intestinal Disease" ], "interventions": [ { "name": "pralsetinib (BLU-667)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 590, "start_date": "2017-03-17", "completion_date": "2024-03-21", "has_results": true, "last_update_posted_date": "2025-05-31", "last_synced_at": "2026-10-23T17:30:38.323Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Orange, California • Aurora, Colorado + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03037385" }, { "nct_id": "NCT06560476", "title": "OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Benign Prostatic Hyperplasia" ], "interventions": [ { "name": "Data collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Urotronic Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 500, "start_date": "2024-03-30", "completion_date": "2027-03-30", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-10-23T17:30:38.323Z", "location_count": 8, "location_summary": "Tampa, Florida • Kearney, Nebraska • Omaha, Nebraska + 5 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Kearney", "state": "Nebraska" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Syosset", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06560476" }, { "nct_id": "NCT00544076", "title": "ED Recovery in Men Age